Kessing, LV, Hansen, MG, Andersen, PK. Course of illness in depressive and bipolar disorders. Naturalistic study, 1994–1999. Br J Psychiatry
2004; 185: 372–7.
Tohen, M, Hennen, J, Zarate, CM Jr, Baldessarini, RJ, Strakowski, SM, Stoll, AL, et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry
2000; 157: 220–8.
Bourne, C, Aydemir, O, Balanza-Martinez, V, Bora, E, Brissos, S, Cavanagh, JT, et al. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand
2013; 128: 149–62.
Kessing, LV, Nilsson, FM. Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses. J Affect Disord
2003; 73: 261–9.
Berk, M, Berk, L, Dodd, S, Cotton, S, Macneil, C, Daglas, R, et al. Stage managing bipolar disorder. In Bipolar Disord
Goodwin, GM, Geddes, JR. Latest maintenance data on lithium in bipolar disorder. Eur Neuropsychopharmacol
2003; 13 (suppl 2): S51–5.
Coryell, W. Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice. Bipolar Disord
2009; 11 (suppl 2): 77–83.
Gray, JD, McEwen, BS. Lithium's role in neural plasticity and its implications for mood disorders. Acta Psychiatr Scand
2013; 128: 347–61.
Grunze, H, Vieta, E, Goodwin, GM, Bowden, C, Licht, RW, Möller, HJ, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry
2013; 14: 154–219.
Kessing, LV, Hansen, HV, Christensen, EM, Dam, H, Gluud, C, Wettersley, J. Do young adults with bipolar disorder benefit from early intervention?
J Affect Disord
2014; 152–154: 403–8.
Kleindienst, N, Engel, R, Greil, W. Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders. Bipolar Disord
2005; 7: 404–17.
Kessing, LV, Hellmund, G, Andersen, PK. Predictors of excellent response to lithium: results from a nationwide register-based study. Int Clin Psychopharmacol
2011; 26: 323–8.
Sachs, GS, Printz, DJ, Kahn, OA, Carpenter, D, Docherty, JP. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. In Postgrad Med
2000; : 1–104.
Licht, RW, Vestergaard, P, Kessing, LV, Larsen, JK, Thomsen, PH. Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr Scand Suppl
2003; 419: 1–22.
Nolen, WA, Kupka, RW, Schulte, PFJ, Knoppert-van der Klein, EAM, Honig, A, et al. Richtlijn Bipolaire Stoornissen (2nd edn) . UtrechtL De Tijdstrom uitgerverij BV, 2008.
Yatham, LN, Kennedy, SH, Parikh, SV, Schaffer, A, Beaulieu, S, Alda, M, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord
2013; 15: 1–44.
Goodwin, GM. Evidence-based guidelines for treating bipolar disorder: revised second edition – recommendations from the British Association for Psychopharmacology. J Psychopharmacol
2009; 23: 346–88.
Munk-Jorgensen, P, Mortensen, PB. The Danish Psychiatric Central Register. Dan Med Bull
1997; 44: 82–4.
Danish Health and Medicines Authority. Medicinal Product Statistics. Danish Health and Medicines Authority, 2002 (http://sundhedsstyrelsen.dk).
Juel, K, Helweg-Larsen, K. The Danish registers of causes of death. Dan Med Bull
1999; 46: 354–7.
Andersen, TF, Madsen, M, Jorgensen, J, Mellemkjaer, L, Olsen, JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull
1999; 46: 263–8.
World Health Organization. Klassifikation af Sygdomme Systematisk del International Statistical [Classification of Diseases and Health Related Problems, Tenth Revision] (Danish Edition). Munksgaard, 1993.
WHO Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs. WHO Collaborating Centre for Drug Statistics Methodology, 2003.
Kessing, LV, Andersen, PK, Mortensen, PB. Predictors of recurrence in affective disorder. A case register study. J Affect Disord
1998; 49: 101–8.
Kessing, LV, Sondergard, L, Kvist, K, Andersen, PK. Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study. Bipolar Disord
2007; 9: 730–6.
Kessing, LV. The effect of comorbid alcoholism on recurrence in affective disorder: a case register study. J Affect Disord
1999; 53: 49–55.
Farren, CK, Hill, KP, Weiss, RD. Bipolar disorder and alcohol use disorder: a review. Curr Psychiatry Rep
2012; 14: 659–66.
Kulhara, P, Basu, D, Mattoo, SK, Sharan, P, Chopra, R. Lithium prophylaxis of recurrent bipolar affective disorder: long-term outcome and its psychosocial correlates. J Affect Disord
1999; 54: 87–96.
Berghofer, A, Alda, M, Adli, M, Baethge, C, Bauer, M, Bschor, T, et al. Long-term effectiveness of lithium in bipolar disorder: a multicenter investigation of patients with typical and atypical features. J Clin Psychiatry
2008; 69: 1860–8.
Pfennig, A, Schlattmann, P, Alda, M, Grof, P, Glenn, T, Müller-Oerlinghausen, B, et al. Influence of atypical features on the quality of prophylactic effectiveness of long-term lithium treatment in bipolar disorders. Bipolar Disord
2010; 12: 390–6.
Maj, M, Pirozzi, R, Magliano, L, Bartoli, L. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic. Am J Psychiatry
1998; 155: 30–5.
Calabrese, JR, Rapport, DJ, Youngstrom, EA, Jackson, K, Bilali, S, Findling, RL. New data on the use of lithium, divalproate, and lamotrigine in rapid cycling bipolar disorder. Eur Psychiatry
2005; 20: 92–5.
Fountoulakis, KN, Kontis, D, Gonda, X, Yatham, LN. A systematic review of the evidence on the treatment of rapid cycling bipolar disorder. Bipolar Disord
2013; 15: 115–37.
Kessing, LV. Diagnostic stability in bipolar disorder in clinical practise as according to ICD-10. J Affect Disord
2005; 85: 293–99.
Perugi, G, Micheli, C, Akiskal, HS, Madaro, D, Socci, C, Quilici, C, et al. Polarity of the first episode, clinical characteristics, and course of manic depressive illness: a systematic retrospective investigation of 320 bipolar I patients. Compr Psychiatry
2000; 41: 13–8.
Geddes, JR, Goodwin, GM, Rendell, J, Azorin, JM, Cipriani, A, Ostacher, MJ, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet
2010; 375: 385–95.
Kessing, LV, Hellmund, G, Geddes, JR, Goodwin, GM, Andersen, PK.
Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. Br J Psychiatry
2011; 199: 57–63.
Kessing, LV, Hellmund, G, Andersen, PK. An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder. J Psychopharmacol
2012; 26: 644–52.
Malhi, GS. The king is dead, long live the king! The restoration of BALANCE. Bipolar Disord
2010; 12: 681–4.
Ghaemi, SN. From BALANCE to DSM-5: taking lithium seriously. Bipolar Disord
2010; 12: 673–7.
Pfennig, A, Bschor, T, Falkai, P, Bauer, M. The diagnosis and treatment of bipolar disorder: recommendations from the current s3 guideline. Dtsch Arztebl Int
2013; 110: 92–100.